6,391,328 Shares in Relmada Therapeutics, Inc. $RLMD Purchased by Spruce Street Capital LP
MarketBeat
Spruce Street Capital LP bought a new stake in Relmada Therapeutics, Inc. (NASDAQ:RLMD - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 6,391,328 shares of the company's stock, valued at approximately $44,227,990,000
NASDAQ:RLMD